Drug
Taspoglutide clinical trials
How studies write it
Studies that test it under each name
Name
- taspoglutide
- 12
Studies by the year they started
13 studies that test it; most in 2008 (7)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 7 |
| 2009 | 2 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses taspoglutide is read from its arms, and is right about nine times in ten.
Testing it · 13
- A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.CompletedPhase 3Hoffmann-La RocheNCT00754988Written as Taspoglutide
- A Study of Taspoglutide in Type 2 Diabetic PatientsCompletedPhase 1Hoffmann-La RocheNCT00811460Written as taspoglutide
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular DiseaseCompletedPhase 3Hoffmann-La RocheNCT01018173Written as taspoglutide
- A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.CompletedPhase 2Hoffmann-La RocheNCT00423501Written as taspoglutide
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.CompletedPhase 3Hoffmann-La RocheNCT00717457Written as taspoglutide
- A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.CompletedPhase 2Hoffmann-La RocheNCT00460941Written as Taspoglutide 20mg
- A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 DiabetesCompletedPhase 3Hoffmann-La RocheNCT00909597Written as taspoglutide
- A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 DiabetesCompletedPhase 3Hoffmann-La RocheNCT00809705Written as taspoglutide
- A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination TherapyTerminatedPhase 3Hoffmann-La RocheNCT01051011Written as taspoglutide
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedPhase 3Hoffmann-La RocheNCT00744367Written as taspoglutide
- A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.CompletedPhase 3Hoffmann-La RocheNCT00755287Written as taspoglutide
- A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin MonotherapyCompletedPhase 3Hoffmann-La RocheNCT00823992Written as taspoglutide
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.CompletedPhase 3Hoffmann-La RocheNCT00744926Written as taspoglutide
Codes
What other systems call taspoglutide · ClinicalTrials.gg INT005452
- MeSH (NLM) C541736taspoglutideOne source NLM
- UNII (FDA) 2PHK27IP3BTASPOGLUTIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q7687607taspoglutideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152518TaspoglutideOne source FDA
- DrugBank DB14027One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C541736 | taspoglutide | One source NLM |
| UNII (FDA) | 2PHK27IP3B | TASPOGLUTIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7687607 | taspoglutide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152518 | Taspoglutide | One source FDA |
| DrugBank | DB14027 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.